Skip to main content

New Discoveries on Calcium Handling in Cardiovascular Pathology

Cover image for Research Topic "New Discoveries on Calcium Handling in Cardiovascular Pathology"
52kviews
Editorial17 July 2024
Editorial: New discoveries on calcium handling in cardiovascular pathology

Understanding how cardiac Ca2+ cycling is altered during disease is fundamental for the development of novel therapeutical strategies to treat myocardial dysfunction. Whereas the functions of classical Ca2+ handling proteins involved in cardiac excitation-contraction coupling (ECC) are well characterized (Bers, 2008; Blatter, 2017), there are secondary regulatory processes of cardiac Ca2+ handling that are less-well understood. This research topic focuses on novel regulatory signaling pathways that have an impact on cardiac myocyte function and contractility.

The atria are subject to atrial fibrillation (AF), the most frequent cardiac arrhythmia diagnosed in human (McManus et al, 2012). AF can originate in both atrial chambers and induces severe remodeling of cardiac tissue, which impairs atrial function and further increases the prevalence of AF. Butova et al. analyzed the contractile function of atrial myocytes (AMs) from left and right atria in a rat animal model for paroxysmal AF. The study shows that AF-induced production of reactive oxygen species (ROS) and downregulation of contractile proteins were not only chamber-specific, but dependent on the preload AMs were exposed to. At higher preload, left AMs were more sensitive to AF-induced damage and showed more efficient remodeling, accompanied by a decrease in contractile function, than right AMs. Thus, hemodynamic load of myocytes affects AF, which represents a novel aspect on chamber-specific differences in cardiac pathologies.

While the molecular mechanisms underlying myocyte contraction are well understood, little is known how myocytes use stretch as a feedback mechanism to control their length. A review by Herrera-Pérez and Lamas highlights the function of TWIK-related K+ channels (TREK) as mechano-transducers in the cardiovascular system. By mediating K+ efflux as a function of membrane stretch, TREK channels contribute to repolarization of the myocyte membrane potential at the end of systole, where myocyte contraction and stretch have reached a maximum. Furthermore, reduced TREK activity during ischemia-reperfusion injuries serves as an electrical substrate for cardiac arrhythmias. In addition, TREK channels of vascular endothelial cells fine-tune NO release in response to shear stress. Therefore, mechano-transduction by TREK channels regulates important physiological parameters of the cardiovascular system, such as cardiac action potential (AP) duration, and metabolic control of blood hemodynamics.

The drug Ibrutinib is a Bruton tyrosine kinase (BTK) inhibitor that is frequently used to treat patients with leukemia. Adverse effects of BTK inhibitors affecting the cardiovascular system include hypertension, AF and ventricular arrhythmias. Tarnowski et al. present a molecular mechanism of how Ibrutinib impairs cardiac Ca2+ handling. In damaged ventricular tissue, endogenous insulin-like growth factor 1 (IGF-1) can improve cardiac contraction by enhancing expression levels and activities of sarco-endoplasmic Ca2+ ATPase (SERCA) or L-type Ca2+ channels. The authors showed that Ibrutinib treatment of myocytes prevented the IGF-1-mediated increase in activities of both Ca2+ handling proteins. This abolished the positive inotropic effect that IGF-1 had in normal ventricular myocytes, demonstrating a molecular mechanism for adverse drug effects on the heart.

Protein phosphatase 2A (PP2A) is a regulatory protein that controls cardiac contractility at many different levels by regulating the phosphorylation status of contractile proteins, Ca2+ release channels and Ca2+ removal proteins, such as the Na+/Ca2+- exchanger (NCX) and SERCA. PP2A itself is controlled by several regulatory subunits and changes in PP2A activity have been described for multiple cardiac diseases (Sergienko et al, 2022). Herting et al. characterized the function of PR72, a regulatory subunit of PP2A, which is upregulated in human HF. By using a transgenic mouse model over-expressing PR72, the authors showed that abundant PR72 caused an increase in intracellular Ca2+ transient amplitude, which translated into hypercontractility of ventricular myocytes and increased ventricular contractile force. Facilitation of Ca2+ release was attributed to a sensitization of SR Ca2+ release channels, enhanced SERCA activity and a downregulation of NCX. This mechanism was interpreted as a putative endogenous mechanism to counteract the reduced contractility in failing myocardium and highlights the functional impact of regulatory proteins on cardiac Ca2+ handling.

A review by Lu et al. focuses on mitochondria-associated membranes (MAM) that form contact sites between the sarcoplasmic reticulum (SR) and mitochondria and which regulate Ca2+ exchange between both organelles. MAM proteins couple inositol trisphosphate receptors (IP3R) or ryanodine receptors type 2 (RyR2) of the SR to mitochondria and regulate mitochondrial Ca2+ content. For some diseases, such as diabetic cardiomyopathy, SR-to-mitochondria Ca2+ coupling is enhanced, causing mitochondrial Ca2+ overload and apoptosis, whereas in other pathologies, such as heart failure (HF), the contact sites are disrupted, leading to metabolic dysfunction. Finally, pathology-related changes in expression levels of MAM are discussed, which are implicated in cardiac dysfunction observed during HF or ischemia-reperfusion injuries.

Excessive production of ROS is a hallmark of the failing myocardium. ROS cause cardiac dysfunction by altering the function of ion channels and Ca2+ handling proteins involved in ECC. Currents carried by voltage-activated Na+ channels, such as the late Na+ current (INa,L), are involved in controlling cardiac excitability and repolarization. INa,L activity is facilitated by protein kinase A (PKA), which is sensitive to ROS, and both, enhanced Na+ influx and enhanced ROS production induce arrythmias during HF (Horváth et al, 2022). A study by Gissibl et al. demonstrates that pharmacological activation of INa,L alone was sufficient to increase cardiac Ca2+ transients and induce ventricular arrythmias, with negligible contribution of the ROS-PKA signaling axis. Instead, increased Na+ influx affected the electrogenic activity of NCX, which caused arrythmias. Of note, INa,L activity resulted in enhanced ROS production in ventricular myocytes by a yet unknown mechanism, which could further impair ventricular contractility via effects secondary to Na+ influx.

In conclusion, the articles presented above highlight how cardiac Ca2+ handling is regulated by novel signaling pathways, such as stretch-activated channels, auxiliary proteins of cardiac enzymes, ROS or proteins associated with MAM. Because signaling of those novel pathways is altered in cardiac pathologies, any knowledge about their function may aid in developing novel therapeutic strategies to treat cardiac dysfunctions.

1,829 views

So close, yet so far away: the relationship between MAM and cardiac disease
REVIEW
5 February 2024
So close, yet so far away: the relationship between MAM and cardiac disease
Bo Lu, 7 more and Deyu Fu
Mitochondria-associated membrane (MAM) serve as crucial contact sites between mitochondria and the endoplasmic reticulum (ER). Recent research has highlighted the significance of MAM, which serve as a platform for various protein molecules, in processes such as calcium signaling, ATP production, mitochondrial structure and function, and autophagy. Cardiac injurydiseases caused by any reason can lead to changes in myocardial structure and function, significantly impacting human health. Notably, MAM exhibits various regulatory effects to maintain cellular balance in several cardiac injurydiseases conditions, such as obesity, diabetes mellitus, and cardiotoxicity. MAM proteins independently or interact with their counterparts, forming essential tethers between the ER and mitochondria in cardiomyocytes. This review provides an overview of key MAM regulators, detailing their structure and functions. Additionally, it explores the connection between MAM and various cardiac injuries, suggesting that precise genetic, pharmacological, and physical regulation of MAM may be a promising strategy for preventing and treating heart failure.

6,004 views

21 citations

Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes
ORIGINAL RESEARCH
15 August 2023
Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes
Daniel Tarnowski, 5 more and Can Martin Sag
Background: The Bruton tyrosine kinase (BTK) inhibitor Ibrutinib is associated with a higher incidence of cardiotoxic side effects including heart failure (HF). Objectives: Ibrutinib is capable of inhibiting PI3K/Akt signaling in neonatal rat ventricular cardiomyocytes when stimulated with insulin-like growth factor 1 (IGF-1). We therefore hypothesized that Ibrutinib might disrupt IGF-1-mediated activation of intracellular Ca handling in adult mouse cardiomyocytes by inhibiting PI3K/Akt signaling. Methods: Isolated ventricular myocytes (C57BL6/J) were exposed to IGF-1 at 10 nmol/L in the presence or absence of Ibrutinib (1 µmol/L) or Acalabrutinib (10 µmol/L; cell culture for 24±2 h). Intracellular Ca handling was measured by epifluorescence (Fura 2 AM) and confocal microscopy (Fluo-4 AM). Ruptured-patch whole-cell voltage-clamp was used to measure ICa. Levels of key cardiac Ca handling proteins were investigated by immunoblots. Results: IGF-1 significantly increased Ca transient amplitudes by ~83 % as compared to vehicle treated control cells. This was associated with unaffected diastolic Ca, enhanced SR Ca loading and increased ICa. Co-treatment with Ibrutinib attenuated both the IGF-1-mediated increase in SR Ca content and in ICa. IGF-1 treated cardiomyocytes had significantly increased levels of pS473Akt/Akt and SERCA2a expression as compared to cells concomitantly treated with IGF-1 and Ibrutinib. SR Ca release (as assessed by Ca spark frequency) was unaffected by either treatment. In order to test for potential off-target effects, second generation BTK inhibitor Acalabrutinib with greater BTK selectivity and lower cardiovascular toxicity was tested for IGF1-mediated activation of intracellular Ca handling. Acalabrutinib induced similar effects on Ca handling in IGF-1 treated cultured myocytes as Ibrutinib in regard to decreased Ca transient amplitude and slowed Ca transient decay, hence implying a functional class effect of BTK inhibitors in cardiac myocytes. Conclusions: Inhibition of BTK by Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in adult ventricular mouse myocytes in the face of disrupted Akt signaling and absent SERCA2a upregulation.

3,232 views

13 citations

ORIGINAL RESEARCH
6 October 2023
Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A
Julius R. Herting, 7 more and Uwe Kirchhefer

4,261 views

3 citations

TREK channels in Mechanotransduction: a Focus on the Cardiovascular System
Mechano-electric feedback is one of the most important subsystems operating in the cardiovascular system, but the underlying molecular mechanism remains rather unknown. Several proteins have been proposed to explain the molecular mechanism of mechano-transduction. Transient receptor potential (TRP) and Piezo channels appear to be the most important candidates to constitute the molecular mechanism behind of the inward current in response to a mechanical stimulus. However, the inhibitory/regulatory processes involving potassium channels that operate on the cardiac system are less well known. TWIK-Related potassium (TREK) channels have emerged as strong candidates due to their capacity for the regulation of the flow of potassium in response to mechanical stimuli. Current data strongly suggest that TREK channels play a role as mechano-transducers in different components of the cardiovascular system, not only at central (heart) but also at peripheral (vascular) level. In this context, this review summarizes and highlights the main existing evidence connecting this important subfamily of potassium channels with the cardiac mechano-transduction process, discussing molecular and biophysical aspects of such a connection.

4,117 views

13 citations

ORIGINAL RESEARCH
7 August 2023
The inter-chamber differences in the contractile function between left and right atrial cardiomyocytes in atrial fibrillation in rats
Xenia Butova, 6 more and Anastasia Khokhlova

3,764 views

9 citations